BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 22239891)

  • 1. Correlation between arterial FDG uptake and biomarkers in peripheral artery disease.
    Myers KS; Rudd JH; Hailman EP; Bolognese JA; Burke J; Pinto CA; Klimas M; Hargreaves R; Dansky HM; Fayad ZA
    JACC Cardiovasc Imaging; 2012 Jan; 5(1):38-45. PubMed ID: 22239891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of inflamed atherosclerotic lesions in vivo using PET-CT.
    Jezovnik MK; Zidar N; Lezaic L; Gersak B; Poredos P
    Inflammation; 2014 Apr; 37(2):426-34. PubMed ID: 24282108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.
    Hetterich H; Rominger A; Walter L; Habs M; Volpers S; Hacker M; Reiser MF; Bartenstein P; Saam T
    Int J Cardiovasc Imaging; 2016 Jan; 32(1):49-59. PubMed ID: 25898891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study.
    Rudd JH; Myers KS; Bansilal S; Machac J; Woodward M; Fuster V; Farkouh ME; Fayad ZA
    Circ Cardiovasc Imaging; 2009 Mar; 2(2):107-15. PubMed ID: 19808576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study.
    Duivenvoorden R; Mani V; Woodward M; Kallend D; Suchankova G; Fuster V; Rudd JHF; Tawakol A; Farkouh ME; Fayad ZA
    JACC Cardiovasc Imaging; 2013 Oct; 6(10):1087-1094. PubMed ID: 24135322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating vulnerable atheroma using combined (18)F-FDG PET/CT angiography of carotid plaque with immunohistochemical validation.
    Menezes LJ; Kotze CW; Agu O; Richards T; Brookes J; Goh VJ; Rodriguez-Justo M; Endozo R; Harvey R; Yusuf SW; Ell PJ; Groves AM
    J Nucl Med; 2011 Nov; 52(11):1698-703. PubMed ID: 21990578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging Intraplaque Inflammation in Carotid Atherosclerosis With 18F-Fluorocholine Positron Emission Tomography-Computed Tomography: Prospective Study on Vulnerable Atheroma With Immunohistochemical Validation.
    Vöö S; Kwee RM; Sluimer JC; Schreuder FH; Wierts R; Bauwens M; Heeneman S; Cleutjens JP; van Oostenbrugge RJ; Daemen JW; Daemen MJ; Mottaghy FM; Kooi ME
    Circ Cardiovasc Imaging; 2016 May; 9(5):. PubMed ID: 27162131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of dual MRI and F-FDG PET imaging in predicting vulnerable and inflamed carotid plaque.
    Saito H; Kuroda S; Hirata K; Magota K; Shiga T; Tamaki N; Yoshida D; Terae S; Nakayama N; Houkin K
    Cerebrovasc Dis; 2013; 35(4):370-7. PubMed ID: 23635390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of FDG uptake in the arterial wall as an imaging biomarker of atherosclerotic plaques with 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT).
    Bucci M; Aparici CM; Hawkins R; Bacharach S; Schrek C; Cheng S; Tong E; Arora S; Parati E; Wintermark M
    J Neuroimaging; 2014; 24(2):117-23. PubMed ID: 22928741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thresholds for Arterial Wall Inflammation Quantified by
    van der Valk FM; Verweij SL; Zwinderman KA; Strang AC; Kaiser Y; Marquering HA; Nederveen AJ; Stroes ES; Verberne HJ; Rudd JH
    JACC Cardiovasc Imaging; 2016 Oct; 9(10):1198-1207. PubMed ID: 27639759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries.
    Silvera SS; Aidi HE; Rudd JH; Mani V; Yang L; Farkouh M; Fuster V; Fayad ZA
    Atherosclerosis; 2009 Nov; 207(1):139-43. PubMed ID: 19467659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular Inflammation in Subclinical Atherosclerosis Detected by Hybrid PET/MRI.
    Fernández-Friera L; Fuster V; López-Melgar B; Oliva B; Sánchez-González J; Macías A; Pérez-Asenjo B; Zamudio D; Alonso-Farto JC; España S; Mendiguren J; Bueno H; García-Ruiz JM; Ibañez B; Fernández-Ortiz A; Sanz J
    J Am Coll Cardiol; 2019 Apr; 73(12):1371-1382. PubMed ID: 30922468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET/CT imaging of integrin αvβ3 expression in human carotid atherosclerosis.
    Beer AJ; Pelisek J; Heider P; Saraste A; Reeps C; Metz S; Seidl S; Kessler H; Wester HJ; Eckstein HH; Schwaiger M
    JACC Cardiovasc Imaging; 2014 Feb; 7(2):178-87. PubMed ID: 24412187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of age and cardiovascular risk factors on (18)F-FDG PET/CT quantification of atherosclerosis in the aorta and peripheral arteries.
    Pasha AK; Moghbel M; Saboury B; Gharavi MH; Blomberg BA; Torigian DA; Kwee TC; Basu S; Mohler Iii ER; Alavi A
    Hell J Nucl Med; 2015; 18(1):5-10. PubMed ID: 25679072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased microvascularization and vessel permeability associate with active inflammation in human atheromata.
    Taqueti VR; Di Carli MF; Jerosch-Herold M; Sukhova GK; Murthy VL; Folco EJ; Kwong RY; Ozaki CK; Belkin M; Nahrendorf M; Weissleder R; Libby P
    Circ Cardiovasc Imaging; 2014 Nov; 7(6):920-9. PubMed ID: 25170063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflamed human carotid plaques evaluated by PET/CT exhibit increased temperature: insights from an in vivo study.
    Toutouzas K; Koutagiar I; Benetos G; Aggeli C; Georgakopoulos A; Athanasiadis E; Pianou N; Trachanellis S; Patelis N; Agrogiannis G; Kafouris P; Filis K; Bessias N; Klonaris C; Spyrou G; Tsiamis E; Siores E; Patsouris E; Cokkinos D; Tousoulis D; Anagnostopoulos CD
    Eur Heart J Cardiovasc Imaging; 2017 Nov; 18(11):1236-1244. PubMed ID: 28011672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations.
    Rudd JH; Myers KS; Bansilal S; Machac J; Pinto CA; Tong C; Rafique A; Hargeaves R; Farkouh M; Fuster V; Fayad ZA
    J Nucl Med; 2008 Jun; 49(6):871-8. PubMed ID: 18483100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of ultrasmall superparamagnetic iron-oxide (USPIO) enhanced MRI with ferumoxytol to quantify arterial wall inflammation.
    Smits LP; Tiessens F; Zheng KH; Stroes ES; Nederveen AJ; Coolen BF
    Atherosclerosis; 2017 Aug; 263():211-218. PubMed ID: 28662398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular Positron Emission Tomography and Restenosis in Symptomatic Peripheral Arterial Disease: A Prospective Clinical Study.
    Chowdhury MM; Tarkin JM; Albaghdadi MS; Evans NR; Le EPV; Berrett TB; Sadat U; Joshi FR; Warburton EA; Buscombe JR; Hayes PD; Dweck MR; Newby DE; Rudd JHF; Coughlin PA
    JACC Cardiovasc Imaging; 2020 Apr; 13(4):1008-1017. PubMed ID: 31202739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT).
    Mehta NN; Torigian DA; Gelfand JM; Saboury B; Alavi A
    J Vis Exp; 2012 May; (63):e3777. PubMed ID: 22588186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.